Loader
Latest News
HR4531: Support for Patients and Communities Reauthorization Act (118th Congress)
20489
wp-singular,page-template-default,page,page-id-20489,wp-theme-bridge,bridge-core-3.3.4.9,qode-optimizer-1.2.3,qode-page-transition-enabled,ajax_fade,page_not_loaded,,qode_grid_1400,side_menu_slide_from_right,qode-theme-ver-30.8.9.1,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-9.0.1,vc_responsive
 

HR4531: Support for Patients and Communities Reauthorization Act

118th Congress (2023–2025) · House bill · Sponsor: Rep. Guthrie, Brett [R-KY-2]

This page covers HR4531 in the 118th Congress. Bill numbers start over every Congress, so HR4531 in another Congress is a different bill. Other bills numbered HR4531 are listed below.


Key facts

Item Detail
Roll-call votes 1
Chamber House
Latest vote 2023-12-12: Passed
Latest action 2023-12-13: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Policy area Health
Official record Congress.gov

What the bill does

Support for Patients and Communities Reauthorization Act This bill reauthorizes through FY2028 and modifies various grants, programs, and activities that address substance use and misuse. This includes reauthorizing (1) data collection, education, and surveillance activities; (2) grants and other support for substance use disorder prevention, treatment, and recovery; (3) student loan repayment and other programs for the substance use disorder workforce; and (4) programs for addressing trauma, particularly for children, youth, and their families. Generally, the modifications expand programs. Additionally, the bill modifies provisions related to the scheduling of controlled substances, including by incorporating illicit xylazine (a compound used in veterinary medicine as a nonopioid tranquilizer) into schedule III of the Controlled Substances Act. Further, the bill makes permanent a requirement that Medicaid programs cover medication-assisted treatment for individuals with substance use disorders.

Subjects: Administrative law and regulatory procedures, Cardiovascular and respiratory health, Child safety and welfare, Computers and information technology, Congressional oversight, Department of Health and Human Services, Digestive and metabolic diseases, Drug safety, medical device, and laboratory regulation, Drug trafficking and controlled substances, Drug, alcohol, tobacco use


Roll-call votes on HR4531 (118th Congress)

Every recorded vote on this bill, newest first, with a link to the official tally. Member-by-member positions are on each member’s profile.

Date Chamber Question Result Yea Nay Not voting Record
2023-12-12 House 2/3 Yea-And-Nay Passed 326 31 7 Official tally

Other bills numbered HR4531

HR4531 in the 117th Congress (2021–2023): 7(a) Loan Agent Oversight Act


Frequently asked

What is HR4531 in the 118th Congress?

HR4531 (Support for Patients and Communities Reauthorization Act) was introduced in the 118th Congress (2023–2025) by Rep. Guthrie, Brett [R-KY-2].

What is the latest action on HR4531?

On 2023-12-13: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

How many roll-call votes were held on HR4531?

1 recorded vote in the 118th Congress. The most recent, on 2023-12-12, was "2/3 Yea-And-Nay": Passed.

Is this the same bill as HR4531 in other Congresses?

No. Bill numbers restart each Congress. HR4531 was also used in the 117th Congress for different legislation.